Related Experiment Video
Updated: Sep 22, 2025

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
Drug Safety in Episodic Migraine Management in Adults. Part 2: Preventive Treatments
Abigail L Chua1, Sandhya Mehla2, Yulia Y Orlova3
1Geisinger Health Systems, Neurology, 1000 E. Mountain Boulevard, Wilkes-Barre, PA, 18711, USA. achua@geisinger.edu.
Purpose Of Review:
The aim of this review is to aid in decision-making when choosing safe and effective options for preventive migraine medications.
Recent Findings:
In Part 2, we have compiled clinically relevant safety considerations for commonly used migraine prophylactic treatments. Preventive treatment of episodic migraine includes nonspecific and migraine-specific drugs. While medications from several pharmacological classes-such as anticonvulsants, beta-blockers, and antidepressants-have an established efficacy in migraine prevention, they are associated with a number of side effects. The safety of migraine-specific treatments such as anti-CGRP monoclonal antibodies and gepants are also discussed. This review highlights safety concerns of commonly used migraine prophylactic agents and offers suggestions on how to mitigate those risks.
Related Concept Videos
Mania and Antimanic Drugs: Overview
Management of Insomnia
Antiepileptic Drugs: Glutamate Antagonists
Antidepressant Drugs: MAOIs and Other Agents
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Drug Therapy
Antianxiety Medications

